Primary practice
Kettering Independent Medical Group Inc
Dayton, Ohio
Find Dr. Reid's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Reid practices at Kettering Independent Medical Group Inc in Dayton, Ohio.
Dr. Reid's NPI, 1245296409, was assigned on April 25, 2006. Dr. Reid graduated from Wright State University Boonshoft School of Medicine in 1996. Dr. Reid holds Ohio license 35-073345.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Reid's primary practice is Kettering Independent Medical Group Inc, at 3700 Southern Blvd, Dayton, OH 45429 in Montgomery County. The practice phone is (937) 762-1629.
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Reid's primary practice is Kettering Independent Medical Group Inc in Dayton, Ohio. Dr. Reid is also affiliated with Miami Valley Hospital. The medical group on file is Kettering Health Medical Group. Dmand AI also links Dr. Reid to 4 more hospitals, 3 group practices and clinics, 2 medical groups and 1 home health agency, each named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reid practices, 9 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Kettering Independent Medical Group Inc | Available with a free account |
| +9 more sites and 2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Gynecologic oncology is Dr. Reid's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Reid is licensed in Ohio.
Counts of gynecologic oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
CMS data shows 334 Medicare services from Dr. Reid across 6 procedure codes in 2024, for 138 Medicare patients. Medicare paid $32,168 for them.
Medians across 63 gynecologic oncologists in Ohio with Dmand AI profiles that report each measure.
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Reid?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Reid and other gynecologic oncologists in Ohio.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
CMS counts 138 Medicare patients who saw Dr. Reid in 2024. The largest group is 65 to 74, with 67 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Reid's median patient age at 64, with 99% women.
Share of Medicare patients with each condition. A patient can have several.
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Median age 64
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
In 2024, Dr. Reid wrote 681 Medicare Part D claims for 138 patients. 88% of them were for generic drugs. CMS names the drug for 542 of them, across 15 drugs with 11 or more claims each, at $175,301 in total drug cost. In 2023, CMS named 533 claims across 15 drugs.
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Drugs named by CMS: 15 in 2024, 15 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Reid for performance year 2024, reported as part of a group. Dr. Reid accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Reid as offering telehealth. CMS counts 31 procedures of removal of the uterus by Dr. Reid, more than 97% of the clinicians it reports for that procedure.
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
CMS ranks each clinician against every clinician it reports for the same procedure category.
Sources: Doctors and Clinicians National Downloadable File (CMS); Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026; and Doctors and Clinicians Utilization Data (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dmand AI links Dr. Reid to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Ovarian Neoplasms and Ovarian Diseases. Open Payments lists research payments to Dr. Reid that name 1 trial.
Conditions in Dr. Reid's trials
Sources: Open Payments (CMS), 2025 data, released July 7, 2026; ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage
CMS Open Payments shows 24 general payments to Dr. Reid from 10 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 67% of the total. AstraZeneca Pharmaceuticals LP paid the most, $2,966. It also lists 5 research payments totaling $677 from 2017 to 2021, naming 1 clinical trial.
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Reid graduated from Wright State University Boonshoft School of Medicine in 1996.
Source: Dmand AI Professional Profile Data
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
Dr. Thomas J A Reid's NPI number is 1245296409. It was assigned on April 25, 2006, and it is active in the NPI Registry.
Dr. Thomas J A Reid is a gynecologic oncologist in Dayton, Ohio. The primary specialty in the NPI Registry is Gynecologic Oncology Physician (taxonomy code 207VX0201X).
Dr. Reid practices at 3700 Southern Blvd, Dayton, OH 45429. Dr. Reid's primary practice is Kettering Independent Medical Group Inc in Dayton, Ohio. Dmand AI also links Dr. Reid to 4 hospitals, 3 group practices and clinics, 2 medical groups and 1 home health agency.
The practice phone on file for Dr. Reid is (937) 762-1629.
Dr. Reid holds Ohio license 35-073345.
Dr. Reid is affiliated with Miami Valley Hospital. Dmand AI links Dr. Reid to 4 more hospitals.
Dr. Reid is linked to Kettering Health Medical Group. Dmand AI links Dr. Reid to 2 more medical groups.
Yes. CMS data shows Dr. Reid billed Medicare for 334 services in 2024, and Dr. Reid accepts Medicare assignment.
Yes. The CMS Doctors and Clinicians file lists Dr. Reid as offering telehealth services.
Dr. Reid's MIPS final score for performance year 2024 is 81 out of 100, reported as part of a group.
CMS counts 138 Medicare patients who saw Dr. Reid in 2024, with an average age of 73.
In 2024, Dr. Reid's most billed Medicare services were office visit, established patient (99215), medicare service (G2211) and office visit, established patient (99214).
Dr. Reid graduated from Wright State University Boonshoft School of Medicine in 1996.
In 2024 Medicare Part D data, Dr. Reid's most prescribed drugs by claims were Ondansetron HCl, Prochlorperazine Maleate and Magnesium Sulfate.
CMS Open Payments shows $4,161 in general payments to Dr. Reid from 10 companies from 2016 to 2024. The largest total came from AstraZeneca Pharmaceuticals LP.
Dr. Reid graduated from medical school in 1996, 30 years ago.
Dr. Reid has worked on 1 clinical trial.
Selling to gynecologic oncology practices?
See gynecologic oncologists in Ohio by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.